Sensei Biotherapeutics, Inc.
SNSE
$0.3857
-$0.0192-4.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.16M | -29.80M | -29.67M | -31.92M | -34.10M |
| Total Depreciation and Amortization | 1.32M | 1.32M | 1.32M | 1.32M | 1.35M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.65M | 4.58M | 4.88M | 5.25M | 5.06M |
| Change in Net Operating Assets | -489.00K | -1.14M | -763.00K | -2.56M | -4.33M |
| Cash from Operations | -24.67M | -25.04M | -24.23M | -27.90M | -32.02M |
| Capital Expenditure | -146.00K | -146.00K | -146.00K | -66.00K | -180.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 157.00K | 166.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.59M | 34.00M | 29.40M | 41.78M | 38.43M |
| Cash from Investing | 22.44M | 33.85M | 29.25M | 41.87M | 38.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -811.00K | -800.00K | -786.00K | -774.00K | -761.00K |
| Issuance of Common Stock | 34.00K | 38.00K | 38.00K | 48.00K | 48.00K |
| Repurchase of Common Stock | -10.00K | -262.00K | -2.61M | -10.39M | -10.46M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -787.00K | -1.02M | -3.35M | -11.12M | -11.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.02M | 7.79M | 1.67M | 2.85M | -4.78M |